AU684877B2 - Indoline derivatives, method of preparation and their use as pharmaceuticals - Google Patents

Indoline derivatives, method of preparation and their use as pharmaceuticals Download PDF

Info

Publication number
AU684877B2
AU684877B2 AU12743/95A AU1274395A AU684877B2 AU 684877 B2 AU684877 B2 AU 684877B2 AU 12743/95 A AU12743/95 A AU 12743/95A AU 1274395 A AU1274395 A AU 1274395A AU 684877 B2 AU684877 B2 AU 684877B2
Authority
AU
Australia
Prior art keywords
formula
compound
compounds
international
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU12743/95A
Other languages
English (en)
Other versions
AU1274395A (en
Inventor
Malcolm Clive Carter
Peter Charles North
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU1274395A publication Critical patent/AU1274395A/en
Application granted granted Critical
Publication of AU684877B2 publication Critical patent/AU684877B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU12743/95A 1993-12-22 1994-12-20 Indoline derivatives, method of preparation and their use as pharmaceuticals Ceased AU684877B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939326192A GB9326192D0 (en) 1993-12-22 1993-12-22 Chemical compounds
GB9326192 1993-12-22
PCT/EP1994/004220 WO1995017405A1 (en) 1993-12-22 1994-12-20 Indoline derivatives, method of preparation and their use as pharmaceuticals

Publications (2)

Publication Number Publication Date
AU1274395A AU1274395A (en) 1995-07-10
AU684877B2 true AU684877B2 (en) 1998-01-08

Family

ID=10747030

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12743/95A Ceased AU684877B2 (en) 1993-12-22 1994-12-20 Indoline derivatives, method of preparation and their use as pharmaceuticals

Country Status (15)

Country Link
US (1) US5633276A (enExample)
EP (1) EP0736028A1 (enExample)
JP (1) JPH09507057A (enExample)
AP (1) AP535A (enExample)
AU (1) AU684877B2 (enExample)
CA (1) CA2179402A1 (enExample)
CO (1) CO4340623A1 (enExample)
GB (1) GB9326192D0 (enExample)
IL (1) IL112097A (enExample)
IS (1) IS4244A (enExample)
MY (1) MY131641A (enExample)
SV (1) SV1994000083A (enExample)
TW (1) TW291479B (enExample)
WO (1) WO1995017405A1 (enExample)
ZA (1) ZA9410056B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2741799B1 (fr) * 1995-12-04 1998-01-02 Oreal Utilisation de melatonine dans une composition pour traiter les signes cutanes des etats de fatigue
CZ291626B6 (cs) * 1996-03-08 2003-04-16 Takeda Chemical Industries, Ltd. Tricyklické sloučeniny, způsob výroby a použití
US6034239A (en) * 1996-03-08 2000-03-07 Takeda Chemical Industries, Ltd. Tricyclic compounds, their production and use
EP1199304A1 (en) * 1997-03-05 2002-04-24 Takeda Chemical Industries, Ltd. Bicyclic compounds and pharmaceutical composition containing tricyclic compound for treating or preventing sleep disorders
TW476758B (en) * 1996-12-10 2002-02-21 Bristol Myers Squibb Co Benzodioxole, benzofuran, dihydrobenzofuran and benzodioxane melatonergic agents
AU6540598A (en) * 1997-03-05 1998-09-22 Bristol-Myers Squibb Company Polycyclic ethyl alkylamide melatonergic agents
FR2763335B1 (fr) * 1997-05-16 2000-11-24 Adir Nouveaux composes heterocycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU727654B2 (en) * 1997-06-13 2000-12-21 Yamanouchi Pharmaceutical Co., Ltd. Tricyclic pyrazole derivative
JP2002516859A (ja) * 1998-06-05 2002-06-11 ブリストルーマイヤーズ スクイブ カンパニー メラトニン作動性薬剤であるヘテロ環シスシクロプロパン誘導体
ES2213022T3 (es) 1999-06-30 2004-08-16 Bristol-Myers Squibb Company Derivados de aminopirrolidina heterociclicos utiles como agentes melatonergicos.
GB9918965D0 (en) * 1999-08-11 1999-10-13 Cerebrus Ltd Chemical compounds xxi
EP1213290B1 (en) 1999-08-20 2005-04-20 Takeda Pharmaceutical Company Limited Dihydrobenzofuran derivatives, process for the preparation thereof and agents
AU1603401A (en) * 2000-03-17 2001-10-03 Alcon Universal Ltd Pyranoindoles for treating glaucoma
US7012090B1 (en) 2000-03-17 2006-03-14 Alcon, Inc. Pyranoindoles for treating glaucoma
ES2172415B2 (es) 2000-07-28 2003-11-16 Univ Madrid Complutense Tratamiento del glaucoma y la hipertension ocular por medio de un analogo de la melatonina.
AU2002245104B2 (en) * 2000-12-11 2006-08-17 Testocreme, Llc Topical testosterone formulations and associated methods
US20030096379A1 (en) * 2001-03-28 2003-05-22 Kilgore James L. Method for producing tryptamine derivatives
PE20080122A1 (es) * 2006-03-20 2008-04-24 Takeda Pharmaceutical Agente profilactico o terapeutico para el sindrome de colon irritable
US8273761B2 (en) * 2006-12-08 2012-09-25 Takeda Pharmaceutical Company Limited Tricyclic compound and medical use thereof
ES2331274B1 (es) * 2007-10-25 2010-10-21 Ferrer Internacional, S.A. Compuesto de indolina.
RU2011107443A (ru) * 2008-07-30 2012-09-10 Феррер Интернасионал С.А. (ES) Индаценовые соединения, фармацевтическая композиция и лекарственное средство на их основе, способ их получения и способ лечения или профилактики состояний, связанных с нарушением функционирования систем, регулируемых мелатонином, с их помощью
BR102016024814A2 (pt) 2016-10-24 2018-05-08 Aché Laboratórios Farmacêuticos S.A. composto, processo de obtenção do composto, composição farmacêutica, uso do composto e método de tratamento de desordens psiquiátricas e/ou distúrbios do sono

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043752A1 (fr) * 1980-06-26 1982-01-13 SOCIETE DE RECHERCHES INDUSTRIELLES S.O.R.I. Société anonyme dite: Dérivé de pyranno-indole et son procédé de préparation
EP0207605A1 (en) * 1985-05-21 1987-01-07 Pfizer Inc. Hypoglycemic thiazolidinediones

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4738972A (en) * 1985-05-21 1988-04-19 Pfizer Inc. Hypoglycemic thiazolidinediones

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043752A1 (fr) * 1980-06-26 1982-01-13 SOCIETE DE RECHERCHES INDUSTRIELLES S.O.R.I. Société anonyme dite: Dérivé de pyranno-indole et son procédé de préparation
EP0207605A1 (en) * 1985-05-21 1987-01-07 Pfizer Inc. Hypoglycemic thiazolidinediones

Also Published As

Publication number Publication date
IS4244A (is) 1995-06-23
US5633276A (en) 1997-05-27
AP535A (en) 1996-09-16
WO1995017405A1 (en) 1995-06-29
IL112097A (en) 1998-06-15
ZA9410056B (en) 1995-10-18
MY131641A (en) 2007-08-30
SV1994000083A (es) 1995-07-24
EP0736028A1 (en) 1996-10-09
GB9326192D0 (en) 1994-02-23
CA2179402A1 (en) 1995-06-29
CO4340623A1 (es) 1996-07-30
IL112097A0 (en) 1995-03-15
AP9400706A0 (en) 1995-01-31
TW291479B (enExample) 1996-11-21
JPH09507057A (ja) 1997-07-15
AU1274395A (en) 1995-07-10

Similar Documents

Publication Publication Date Title
AU684877B2 (en) Indoline derivatives, method of preparation and their use as pharmaceuticals
US5455252A (en) Optionally substituted 6,8-quinolines
JP2941309B2 (ja) 化合物
AU679053B2 (en) Indoletetralins having dopaminergic activity
KR930003759B1 (ko) 인돌 유도체의 제조방법
JP3033076B2 (ja) カンナビノイド受容体への親和性を有するインドール誘導体
JP2000515136A (ja) プロテインチロシンキナーゼ阻害剤としての二環式ヘテロ芳香族化合物
JPH0569817B2 (enExample)
IE57809B1 (en) 1,2,3,9-tetrahydro-3-(imidazol-1-ylmethyl)-4h-carbazol-4 one derivatives
JPH08504785A (ja) ５−ｈｔ▲下１▼様アゴニストとしてのトリプタミンアナログ
FR2596049A1 (fr) Derives de dichloroaniline
JPH10502336A (ja) ナフタレン誘導体、製造方法および使用
JP2007277254A (ja) ２−（１ｈ−インドリルスルファニル）−ベンジルアミン誘導体
JPH08512299A (ja) ５ｈｔ▲下２ｃ▼アンタゴニストとしてのインドリン誘導体
JP2000511518A (ja) 時間生物学的薬剤としてのベンゾフランおよびベンゾピラン
US6153641A (en) Pharmaceutically active compounds
JPH11508283A (ja) ベンゾフリル誘導体類及びそれらの用途
FR2567510A1 (fr) Composes d'aminophenol et compositions pharmaceutiques les contenant
CH667454A5 (fr) Derives d'indoles.
JPS62195363A (ja) 化学化合物
JP2941333B2 (ja) インドール誘導体
US5770611A (en) Indole derivatives as 5HT1 -like agonists
US4221788A (en) 2-(Optionally-substituted)benzylperhydroazepines for analgesia and lowering blood pressure
JPH0764843B2 (ja) 新規化合物，その製法及びそれを含む医薬組成物
HU177107B (en) Process for producing new 1-phenyl-ethanolamine derivatives of antyflogistic activity

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired